ENO1 and neoplasm: The in vitro and in vivo experiments demonstrated that tumor-intrinsic ENO1 deficiency impedes tumorigenesis and reshapes the immune landscape of the TME by facilitating the infiltration of CD8+ T cells, suggesting a pivotal role for ENO1 in regulating the tumor immune microenvironment (TIME).